Merlin Guggenheim

Merlin Guggenheim

Auto-generated profile, based on publicly available information

Merlin Guggenheim

Division of Hand, Plastic and Reconstructive Surgery, University Hospital Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Burns
Verified
Journal Article
Closed access
MGMerlin Guggenheim
Merlin Guggenheim
RZReinhard Zbinden
Reinhard Zbinden
AHAlexander E. Handschin
Alexander E. Handschin
AGAndreas Gohritz
Andreas Gohritz
MAMehmet A. Altintas
Mehmet A. Altintas
PGPietro Giovanoli
Pietro Giovanoli

1 April 2008 in Annals of Surgery
Verified
Journal Article
Closed access
MGMerlin M. Guggenheim
Merlin M. Guggenheim
UHUrs Hug
Urs Hug
FJFlorian J. Jung
Florian J. Jung
VRValentin Rousson
Valentin Rousson
MAMatthias C. Aust
Matthias C. Aust
PGPietro Giovanoli
Pietro Giovanoli
To assess the nature and rates of complications and recurrences after completion lymph node dissection (CLND) following positive sentinel lymph node biopsy (SLNB) in melanoma patients. In contrast to SLNB, CLND is associated with considerable morbidity. CLND delays nodal recurrence, thereby prolonging disease-free survival (DFS), but not overall melanoma-specific survival. Elaborate studies on morbidity and recurrence rates after CLND are scarce. Therefore, many controversies concerning extent and nature of CLND exist. We conducted a retrospective study on 100 melanoma patients, on whom we performed CLND between October 1999 and December 2005. The median observation period was 38.8 months. We performed a total of 102 CLNDs, [46.1% axillary (47/102), 42.2% groin (43/102), 11.8% neck (12/102)]. Groin dissection (GD) and axillary dissection (AD) led to comparable morbidity (47.6% and 46.8%), but complications were more severe in GD, mandating additional surgery in 25.6% (11/43), versus 8.5% (4/47) in AD. Of the GD patients, 18.5% (8/43) were readmitted for complications compared with 10.4% (5/47) of AD patients. Only 8.3% (1/12) of ND patients suffered complications, mandating neither readmittance nor further surgery. During the median observation period, 65 (65%) of these patients showed DFS, and 35 (35%) exhibited recurrences after a median DFS of 12.5 months. Of the recurrences, 31.4% were nodal, 42.9% distant, and 25.7% local/in-transit. Of our AD patients, 28.3% suffered recurrences (13/46), as did 33.3% of the GD (14/42) and 66.7% of the ND patients (8/12). CLND is fraught with considerable morbidity. Local control of the dissected nodal basins was achieved with a modified radical approach in ADs (levels I + II only) and, to a lesser extent, GDs, but not in NDs. Clinical trials are necessary to establish guidelines on the extent of lymphatic dissection.

27 May 2008 in British Journal of Cancer
Verified
Journal Article
Open access
MGM Guggenheim
M Guggenheim
RDR Dummer
R Dummer
FJF J Jung
F J Jung
DMD Mihic-Probst
D Mihic-Probst
HSH Steinert
H Steinert
PGP Giovanoli
P Giovanoli
Twenty per cent of sentinel lymph node (SLN)-positive melanoma patients have positive non-SLN lymph nodes in completion lymph node dissection (CLND). We investigated SLN tumour load, non-sentinel positivity and disease-free survival (DFS) to assess whether certain patients could be spared CLND. Sentinel lymph node biopsy was performed on 392 patients between 1999 and 2005. Median observation period was 38.8 months. Sentinel lymph node tumour load did not predict non-SLN positivity: 30.8% of patients with SLN macrometastases (2 mm) and 16.4% with micrometastases (2 mm) had non-SLN positivity (P=0.09). Tumour recurrences after positive SLNs were more than twice as frequent for SLN macrometastases (51.3%) than for micrometastases (24.6%) (P=0.005). For patients with SLN micrometastases, the DFS analysis was worse (P=0.003) when comparing those with positive non-SLNs (60% recurrences) to those without (17.6% recurrences). This difference did not translate into significant differences in DFS: patients with SLN micrometastasis, either with (P=0.022) or without additional positive non-SLNs (P<0.0001), fared worse than patients with tumour-free SLNs. The 2-mm cutoff for SLN tumour load accurately predicts differences in DFS. Non-SLN positivity in CLND, however, cannot be predicted. Therefore, contrary to other studies, no recommendations concerning discontinuation of CLND based on SLN tumour load can be deduced.

1 October 2009 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
AAAhmet A. Altintas
Ahmet A. Altintas
MGMerlin Guggenheim
Merlin Guggenheim
MAMehmet A. Altintas
Mehmet A. Altintas
PAPeymaneh Amini
Peymaneh Amini
TSTilman Stasch
Tilman Stasch
GSGerald Spilker
Gerald Spilker
The purpose of this study was to assess if the healing course of burn wounds of indeterminate depth can be predicted based on serial in vivo reflectance-mode confocal microscopy (RMCM) analysis. Twenty-four patients (mean age, 33.1 ± 11.4 years; mean burn size: 6% TBSA) were investigated at 12, 36, and 72 hours after burn of indeterminate depth and retrospectively grouped into healing group (HG: 16 patients) and nonhealing group (NHG: eight patients). Noninjured skin served as controls. The following parameters were assessed: quantitative blood cell flow (BCF), basal layer thickness (BLT), and inflammatory cells. At 12 hours postburn, BCF increased to 101.67 ± 7.64 cells/min in HG vs 85 ± 50 cells/min in NHG compared with controls (56.5 ± 2.3 cells/min). At 36 and 72 hours, BCF increased to 115 ± 10 cells/min and 125 ± 50 cells/min in HG vs decreased to 80 ± 5 cell/min and 75 ± 5 cells/min in NHG (P < .05). At 12 hours postburn, BLT increased to 19.43 ± 0.93 µm in HG vs 29 ± 1 µm in NHG compared with controls (15.40 ± 0.60 µm, P < .05). In HG, further gradual increase of BLT to 20 ± 1 µm (36 hours) and 21 ± 1 µm (72 hours) was observed, whereas BLT was destroyed after 36 hours in NHG. Qualitative assessment found insignificant amount of IC in controls and low amount in HG until 72 hours postburn, whereas progressive increase in IC from low amount (12 hours) to numerous (36 hours) and massive (72 hours) was observed in NHG. RMCM enables simultaneous evaluation of microcirculation, histomorphology, and inflammatory cell trafficking in burn wounds. RMCM may help to predict whether burns of indeterminate depth have the potential to heal and can be a valuable tool to clinicians to guide early therapeutic decision-making process in burn patients.

1 February 2011 in Microscopy Research and Technique
Verified
Journal Article
Closed access
PDF file
AAAhmet Ali Altintas
Ahmet Ali Altintas
MGMerlin Guggenheim
Merlin Guggenheim
AOArzu Oezcelik
Arzu Oezcelik
BGBenjamin Gehl
Benjamin Gehl
MAMatthias C. Aust
Matthias C. Aust
MAMehmet Ali Altintas
Mehmet Ali Altintas

1 January 2012
Verified
Journal Article
Closed access
BABarbara Bichsel-Von Arb
Barbara Bichsel-Von Arb
JBJosi Bühlmann
Josi Bühlmann
PGPietro Giovanoli
Pietro Giovanoli
MGMerlin Guggenheim
Merlin Guggenheim
TLTobias Lehmann
Tobias Lehmann
RSRebecca Spirig
Rebecca Spirig